• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 3. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate (CAS No. 188359-85-5): An Overview of Its Structure, Synthesis, and Applications

tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate (CAS No. 188359-85-5) is a versatile compound with significant applications in the fields of organic synthesis, pharmaceutical research, and medicinal chemistry. This compound is characterized by its unique structural features, which include a tert-butyl carbamate group and a hydroxyalkenyl moiety. These structural elements contribute to its chemical stability and reactivity, making it an important intermediate in various synthetic pathways.

The structure of tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate can be described as follows: it consists of a tert-butyl group attached to a carbamate functional group, which in turn is bonded to a chiral (2R) hydroxyalkenyl chain. The presence of the chiral center at the 2-position of the pentenyl chain imparts enantiomeric purity to the molecule, which is crucial for its use in chiral synthesis and drug development. The hydroxy group at the 1-position and the double bond at the 4-position further enhance its reactivity and functional versatility.

In terms of synthesis, tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate can be prepared through several methods. One common approach involves the reaction of (2R)-1-hydroxypent-4-en-2-amine with di-tert-butyl dicarbonate (Boc₂O) under mild conditions. This reaction selectively protects the amine functionality while preserving the hydroxy and double bond functionalities. Another method involves the use of organometallic reagents, such as Grignard reagents, to introduce the hydroxyalkenyl moiety onto a pre-existing tert-butyl carbamate scaffold. These synthetic strategies have been extensively studied and optimized in recent years, leading to improved yields and purity levels.

The applications of tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate are diverse and span multiple areas of research. In organic synthesis, it serves as a valuable building block for constructing more complex molecules. Its chiral nature makes it particularly useful in asymmetric synthesis, where it can be used to introduce chirality into target molecules with high enantioselectivity. In pharmaceutical research, this compound has shown promise as an intermediate in the synthesis of bioactive compounds, including potential drug candidates. For example, recent studies have explored its use in the development of inhibitors for specific enzymes involved in disease pathways.

In the context of medicinal chemistry, tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate has been investigated for its potential therapeutic applications. One area of interest is its role as a precursor in the synthesis of small molecule inhibitors targeting protein-protein interactions (PPIs). PPIs are known to play critical roles in various biological processes and are often implicated in disease states such as cancer and neurodegenerative disorders. By modulating these interactions, compounds derived from tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate could offer new therapeutic strategies for treating these conditions.

Furthermore, recent advancements in drug delivery systems have highlighted the importance of compounds like tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate. The tert-butyl carbamate group can be designed to undergo controlled deprotection under specific physiological conditions, releasing active drug molecules at targeted sites. This approach has been explored in the development of prodrugs that enhance bioavailability and reduce side effects compared to traditional drug formulations.

In conclusion, tert-butyl N-(2R)-1-hydroxypent-4-en-2-ylcarbamate (CAS No. 188359-85-5) is a multifaceted compound with significant potential in various scientific disciplines. Its unique structural features, coupled with its synthetic versatility and biological activity, make it an important molecule for ongoing research and development efforts. As new methodologies and applications continue to emerge, this compound is likely to play an increasingly prominent role in advancing our understanding and treatment of complex diseases.

• 128427-10-1((S)-(-)-2-(Boc-amino)-1,4-butanediol)
• 397246-14-9(tert-butyl N-(2R)-1,4-dihydroxybutan-2-ylcarbamate)
• 183247-77-0(Carbamic acid,[1-(hydroxymethyl)-3-butenyl]-, 1,1-dimethylethyl ester (9CI))
• 156627-42-8(tert-butyl N-(1,4-dihydroxybutan-2-yl)carbamate)
• 397246-12-7((R)-2-TERT-BUTYLOXYCARBONYLAMINO-PENTANE-1,5-DIOL)
• 150736-72-4(N-Boc-(S)-2-Amino-1-butanol)
• 150736-71-3(tert-butyl N-[(2R)-1-hydroxybutan-2-yl]carbamate)
• 162955-48-8((S)-(-)-2-(N-Boc-amino)-1,5-pentanediol)
• 225779-17-9(Carbamic acid,N-[(1S)-1-(hydroxymethyl)-4-penten-1-yl]-, 1,1-dimethylethyl ester)
• 193086-15-6(tert-butyl N-(1-hydroxybutan-2-yl)carbamate)